Long-term growth hormone treatment preserves GH-induced memory and mood improvements:: a 10-year follow-up study in GH-deficient adult men

被引:67
|
作者
Arwert, LI
Deijen, JB
Müller, M
Drent, ML
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Endocrinol, NL-1007 MB Amsterdam, Netherlands
[2] Free Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands
关键词
growth hormone; insulin-like growth factor 1; mood; cognition; memory; well-being; quality of life; growth hormone deficiency;
D O I
10.1016/j.yhbeh.2004.11.015
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Growth hormone (GH) replacement therapy with duration of several years is known to be safe and beneficial in GH-deficient adult patients. However, long-term follow-up data on GH substitution, cognition, and well-being are scarce. The purpose of this study was to investigate whether the benefits of GH replacement in psychological functioning found in previous studies lasting up to 2 years are preserved over a 10-year follow-up period. Twenty-three men (mean age at baseline 28.6 years) with childhood-onset GH deficiency were studied during a 10-year period of GH substitution. Memory tasks, mood questionnaires, and IGF-I values were obtained at baseline and after 0.5, 1, 2, 3, 5, and 10 years of GH substitution. Both mood and memory improved during GH therapy. After 6 months of treatment, anxiety and tension were reduced and vigor had improved. Memory improved after 1 year of substitution. These improvements were maintained during the 10-year follow-up period. Higher intra-subject IGF-I levels were associated with better mood (anxiety, tension, vigor). This study shows that 10 years of GH therapy is beneficial in terms of well-being and cognitive functioning in childhood-onset GH-deficient men. It may be concluded that once the decision to start GH treatment has been taken, this may imply that GH therapy has to be continued for a long period to maintain the psychological improvements and to prevent a relapse. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:343 / 349
页数:7
相关论文
共 12 条
  • [11] Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA)
    Isfan, F.
    Kanold, J.
    Merlin, E.
    Contet, A.
    Sirvent, N.
    Rochette, E.
    Poiree, M.
    Terral, D.
    Carla-Malpuech, H.
    Reynaud, R.
    Pereira, B.
    Chastagner, P.
    Simeoni, M. C.
    Auquier, P.
    Michel, G.
    Demeocq, F.
    BONE MARROW TRANSPLANTATION, 2012, 47 (05) : 684 - 693
  • [12] Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA)
    F Isfan
    J Kanold
    E Merlin
    A Contet
    N Sirvent
    E Rochette
    M Poiree
    D Terral
    H Carla-Malpuech
    R Reynaud
    B Pereira
    P Chastagner
    M C Simeoni
    P Auquier
    G Michel
    F Deméocq
    Bone Marrow Transplantation, 2012, 47 : 684 - 693